VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q60328570 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010729.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q60328570‏
024 ‎‡a 0000-0001-9021-2485‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q60328570‏
100 0 ‎‡a Joan Carles Escola-Gil‏ ‎‡c researcher ORCID ID = 0000-0001-9021-2485‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Joan Carles Escola-Gil‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A Functional Virgin Olive Oil Enriched with Olive Oil and Thyme Phenolic Compounds Improves the Expression of Cholesterol Efflux-Related Genes: A Randomized, Crossover, Controlled Trial‏
670 ‎‡a Author's Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice‏
670 ‎‡a Author's Altered Brain Metabolome Is Associated with Memory Impairment in the rTg4510 Mouse Model of Tauopathy‏
670 ‎‡a Author's Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice‏
670 ‎‡a Author's ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.‏
670 ‎‡a Author's APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm.‏
670 ‎‡a Author's Apolipoprotein Mimetics in Cancer‏
670 ‎‡a Author's Are LXR-regulated genes a major molecular target of plant sterols/stanols?‏
670 ‎‡a Author's ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways.‏
670 ‎‡a Author's CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection‏
670 ‎‡a Author's Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness‏
670 ‎‡a Author's Cholesterol efflux and reverse cholesterol transport‏
670 ‎‡a Author's Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice‏
670 ‎‡a Author's Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.‏
670 ‎‡a Author's Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport‏
670 ‎‡a Author's Cross-Talk between Inflammatory Mediators and the Epithelial Mesenchymal Transition Process in the Development of Thyroid Carcinoma.‏
670 ‎‡a Author's Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation‏
670 ‎‡a Author's Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.‏
670 ‎‡a Author's Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity‏
670 ‎‡a Author's Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.‏
670 ‎‡a Author's Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia‏
670 ‎‡a Author's Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: cholesterol acyltransferase deficiency‏
670 ‎‡a Author's Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus‏
670 ‎‡a Author's HDL and LDL: Potential New Players in Breast Cancer Development‏
670 ‎‡a Author's HDL and lifestyle interventions‏
670 ‎‡a Author's Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.‏
670 ‎‡a Author's Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.‏
670 ‎‡a Author's Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice‏
670 ‎‡a Author's Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.‏
670 ‎‡a Author's Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.‏
670 ‎‡a Author's Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet‏
670 ‎‡a Author's Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake‏
670 ‎‡a Author's Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.‏
670 ‎‡a Author's Identification and validation of common molecular targets of hydroxytyrosol‏
670 ‎‡a Author's IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features‏
670 ‎‡a Author's Impaired HDL‏
670 ‎‡a Author's Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm-Brief Report‏
670 ‎‡a Author's Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes‏
670 ‎‡a Author's Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.‏
670 ‎‡a Author's Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity‏
670 ‎‡a Author's Low-density lipoproteins from embryonic cerebrospinal fluid are required for neural differentiation‏
670 ‎‡a Author's LXR-dependent regulation of macrophage-specific reverse cholesterol transport is impaired in a model of genetic diabesity.‏
670 ‎‡a Author's Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression‏
670 ‎‡a Author's Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: A possible role for interleukin-6‏
670 ‎‡a Author's Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse‏
670 ‎‡a Author's Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.‏
670 ‎‡a Author's Modulation of autoimmune arthritis severity in mice by apolipoprotein E‏
670 ‎‡a Author's Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.‏
670 ‎‡a Author's Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.‏
670 ‎‡a Author's Molecular Insights into the Mechanisms Underlying the Cholesterol- Lowering Effects of Phytosterols‏
670 ‎‡a Author's Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice‏
670 ‎‡a Author's Pharmacological activation of LXR alters the expression profile of tumor-associated macrophages and the abundance of regulatory T cells in the tumor microenvironment‏
670 ‎‡a Author's Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo‏
670 ‎‡a Author's Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration.‏
670 ‎‡a Author's Phytosterols and Health: Current Status and Future Perspectives‏
670 ‎‡a Author's Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer.‏
670 ‎‡a Author's Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis‏
670 ‎‡a Author's PPAR-β/δ activation promotes phospholipid transfer protein expression.‏
670 ‎‡a Author's Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport.‏
670 ‎‡a Author's Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.‏
670 ‎‡a Author's Seeking Novel Targets for Improving In Vivo Macrophage-Specific Reverse Cholesterol Transport: Translating Basic Science into New Therapies for the Prevention and Treatment of Atherosclerosis‏
670 ‎‡a Author's Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes‏
670 ‎‡a Author's Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice‏
670 ‎‡a Author's The Cholesterol Content of Western Diets Plays a Major Role in the Paradoxical Increase in High-Density Lipoprotein Cholesterol and Upregulates the Macrophage Reverse Cholesterol Transport Pathway‏
670 ‎‡a Author's The results in rodent models of atherosclerosis are not interchangeable‏
670 ‎‡a Author's Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function‏
670 ‎‡a Author's VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.‏
909 ‎‡a (orcid) 0000000190212485‏ ‎‡9 1‏
919 ‎‡a vldlandapolipoprotein103induceerstressandinflammationandattenuateinsulinsignallingviatolllikereceptor2inmouseskeletalmusclecells‏ ‎‡A VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.‏ ‎‡9 1‏
919 ‎‡a trimethylamineoxidealinkamongdietgutmicrobiotageneregulationofliverandintestinecholesterolhomeostasisandhdlfunction‏ ‎‡A Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function‏ ‎‡9 1‏
919 ‎‡a resultsinrodentmodelsofatherosclerosisarenotinterchangeable‏ ‎‡A The results in rodent models of atherosclerosis are not interchangeable‏ ‎‡9 1‏
919 ‎‡a cholesterolcontentofwesterndietsplaysamajorroleintheparadoxicalincreaseinhighdensitylipoproteincholesterolandupregulatesthemacrophagereversecholesteroltransportpathway‏ ‎‡A The Cholesterol Content of Western Diets Plays a Major Role in the Paradoxical Increase in High-Density Lipoprotein Cholesterol and Upregulates the Macrophage Reverse Cholesterol Transport Pathway‏ ‎‡9 1‏
919 ‎‡a subcutaneousadministrationofapolipoproteinjderivedmimeticpeptide500apojimprovesldlandhdlfunctionandpreventsatherosclerosisinldlrkomice‏ ‎‡A Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice‏ ‎‡9 1‏
919 ‎‡a serummicrorna1andmicrorna133alevelsreflectmyocardialsteatosisinuncomplicatedtype2diabetes‏ ‎‡A Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes‏ ‎‡9 1‏
919 ‎‡a seekingnoveltargetsforimprovinginvivomacrophagespecificreversecholesteroltransporttranslatingbasicscienceintonewtherapiesforthepreventionandtreatmentofatherosclerosis‏ ‎‡A Seeking Novel Targets for Improving In Vivo Macrophage-Specific Reverse Cholesterol Transport: Translating Basic Science into New Therapies for the Prevention and Treatment of Atherosclerosis‏ ‎‡9 1‏
919 ‎‡a resveratroladministrationorsirt1overexpressiondoesnotincreaselxrsignalingandmacrophagetofecesreversecholesteroltransportinvivo‏ ‎‡A Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.‏ ‎‡9 1‏
919 ‎‡a quantificationofinvitromacrophagecholesteroleffluxandinvivomacrophagespecificreversecholesteroltransport‏ ‎‡A Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport.‏ ‎‡9 1‏
919 ‎‡a pparβδactivationpromotesphospholipidtransferproteinexpression‏ ‎‡A PPAR-β/δ activation promotes phospholipid transfer protein expression.‏ ‎‡9 1‏
919 ‎‡a pitfallsofdirecthdlcholesterolmeasurementsinmousemodelsofhyperlipidemiaandatherosclerosis‏ ‎‡A Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis‏ ‎‡9 1‏
919 ‎‡a phytosterolsinhibitthetumorgrowthandlipoproteinoxidizabilityinducedbyahighfatdietinmicewithinheritedbreastcancer‏ ‎‡A Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer.‏ ‎‡9 1‏
919 ‎‡a phytosterolsandhealthcurrentstatusandfutureperspectives‏ ‎‡A Phytosterols and Health: Current Status and Future Perspectives‏ ‎‡9 1‏
919 ‎‡a phenytointreatmentreducesatherosclerosisinmicethroughmechanismsindependentofplasmahdlcholesterolconcentration‏ ‎‡A Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration.‏ ‎‡9 1‏
919 ‎‡a phenolenrichedvirginoliveoilpromotesmacrophagespecificreversecholesteroltransportinvivo‏ ‎‡A Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo‏ ‎‡9 1‏
919 ‎‡a pharmacologicalactivationoflxralterstheexpressionprofileoftumorassociatedmacrophagesandtheabundanceofregulatorytcellsinthetumormicroenvironment‏ ‎‡A Pharmacological activation of LXR alters the expression profile of tumor-associated macrophages and the abundance of regulatory T cells in the tumor microenvironment‏ ‎‡9 1‏
919 ‎‡a nicotinamidepreventsapolipoproteinbcontaininglipoproteinoxidationinflammationandatherosclerosisinapolipoproteinedeficientmice‏ ‎‡A Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice‏ ‎‡9 1‏
919 ‎‡a molecularinsightsintothemechanismsunderlyingthecholesterolloweringeffectsofphytosterols‏ ‎‡A Molecular Insights into the Mechanisms Underlying the Cholesterol- Lowering Effects of Phytosterols‏ ‎‡9 1‏
919 ‎‡a molecularanalysisofchylomicronemiainaclinicallaboratorysettingdiagnosisof13casesoflipoproteinlipasedeficiency‏ ‎‡A Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.‏ ‎‡9 1‏
919 ‎‡a modulationofautoimmunearthritisseverityinmicebyapolipoproteineapoeandcholesterol‏ ‎‡A Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.‏ ‎‡9 1‏
919 ‎‡a modulationofautoimmunearthritisseverityinmicebyapolipoproteine‏ ‎‡A Modulation of autoimmune arthritis severity in mice by apolipoprotein E‏ ‎‡9 1‏
919 ‎‡a methionineinducedhyperhomocysteinemiaimpairstheantioxidantabilityofhighdensitylipoproteinswithoutreducinginvivomacrophagespecificreversecholesteroltransport‏ ‎‡A Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.‏ ‎‡9 1‏
919 ‎‡a mastcellactivationinvivoimpairsthemacrophagereversecholesteroltransportpathwayinthemouse‏ ‎‡A Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse‏ ‎‡9 1‏
919 ‎‡a manipulationofinflammationmodulateshyperlipidemiainapolipoproteinedeficientmiceapossibleroleforinterleukin6‏ ‎‡A Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: A possible role for interleukin-6‏ ‎‡9 1‏
919 ‎‡a macrophagecholesteroleffluxdownregulationisnotassociatedwithabdominalaorticaneurysmaaaprogression‏ ‎‡A Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression‏ ‎‡9 1‏
919 ‎‡a lxrdependentregulationofmacrophagespecificreversecholesteroltransportisimpairedinamodelofgeneticdiabesity‏ ‎‡A LXR-dependent regulation of macrophage-specific reverse cholesterol transport is impaired in a model of genetic diabesity.‏ ‎‡9 1‏
919 ‎‡a lowdensitylipoproteinsfromembryoniccerebrospinalfluidarerequiredforneuraldifferentiation‏ ‎‡A Low-density lipoproteins from embryonic cerebrospinal fluid are required for neural differentiation‏ ‎‡9 1‏
919 ‎‡a lowdensitylipoproteinreceptorrelatedprotein1deficiencyincardiomyocytesreducessusceptibilitytoinsulinresistanceandobesity‏ ‎‡A Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity‏ ‎‡9 1‏
919 ‎‡a liver10receptormediatedactivationofreversecholesteroltransportfrommacrophagestofecesinvivorequiresabcg5g8‏ ‎‡A Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.‏ ‎‡9 1‏
919 ‎‡a lipoproteinhydrophobiccorelipidsarepartiallyextrudedtosurfaceinsmallerhdlherniatedhdlacommonfeatureindiabetes‏ ‎‡A Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes‏ ‎‡9 1‏
919 ‎‡a impairedhdlhighdensitylipoproteinmediatedmacrophagecholesteroleffluxinpatientswithabdominalaorticaneurysmbriefreport‏ ‎‡A Impaired HDL (High-Density Lipoprotein)-Mediated Macrophage Cholesterol Efflux in Patients With Abdominal Aortic Aneurysm-Brief Report‏ ‎‡9 1‏
919 ‎‡a impairedhdl‏ ‎‡A Impaired HDL‏ ‎‡9 1‏
919 ‎‡a iggantihighdensitylipoproteinantibodiesareelevatedinabdominalaorticaneurysmandassociatedwithlipidprofileandclinicalfeatures‏ ‎‡A IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features‏ ‎‡9 1‏
919 ‎‡a identificationandvalidationofcommonmoleculartargetsofhydroxytyrosol‏ ‎‡A Identification and validation of common molecular targets of hydroxytyrosol‏ ‎‡9 1‏
919 ‎‡a humanscavengerproteinaimincreasesfoamcellformationandcd36mediatedoxldluptake‏ ‎‡A Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.‏ ‎‡9 1‏
919 ‎‡a humanhepaticlipaseoverexpressioninmiceinduceshepaticsteatosisandobesitythroughpromotinghepaticlipogenesisandwhiteadiposetissuelipolysisandfattyaciduptake‏ ‎‡A Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake‏ ‎‡9 1‏
919 ‎‡a humanapolipoproteina2isaproatherogenicmoleculewhenitisexpressedintransgenicmiceatalevelsimilartothatinhumansevidenceofapotentiallyrelevantspeciesspecificinteractionwithdiet‏ ‎‡A Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet‏ ‎‡9 1‏
919 ‎‡a humanapolipoproteina2enrichmentdisplacesparaoxonasefromhdlandimpairsitsantioxidantpropertiesanewmechanismlinkinghdlproteincompositionandantiatherogenicpotential‏ ‎‡A Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.‏ ‎‡9 1‏
919 ‎‡a humanapolipoproteina2determinesplasmatriglyceridesbyregulatinglipoproteinlipaseactivityandhighdensitylipoproteinproteome‏ ‎‡A Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.‏ ‎‡9 1‏
919 ‎‡a humanapoa1overexpressionenhancesmacrophagespecificreversecholesteroltransportbutfailstopreventinheriteddiabesityinmice‏ ‎‡A Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice‏ ‎‡9 1‏
919 ‎‡a hepaticregulationofvldlreceptorbypparβδandfgf21modulatesnonalcoholicfattyliverdisease‏ ‎‡A Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.‏ ‎‡9 1‏
919 ‎‡a hepaticlipaseandendotheliallipasedeficiencyinmicepromotesmacrophagetofecesrctandhdlantioxidantproperties‏ ‎‡A Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.‏ ‎‡9 1‏
919 ‎‡a hdlandlifestyleinterventions‏ ‎‡A HDL and lifestyle interventions‏ ‎‡9 1‏
919 ‎‡a hdlandldlpotentialnewplayersinbreastcancerdevelopment‏ ‎‡A HDL and LDL: Potential New Players in Breast Cancer Development‏ ‎‡9 1‏
919 ‎‡a genevariantandlevelofil1βinischemicstrokepatientswithandwithouttype2diabetesmellitus‏ ‎‡A Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus‏ ‎‡9 1‏
919 ‎‡a freecholesteroldepositioninthecorneaofhumanapolipoproteina2transgenicmicewithfunctionallecithincholesterolacyltransferasedeficiency‏ ‎‡A Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: cholesterol acyltransferase deficiency‏ ‎‡9 1‏
919 ‎‡a expressionofhumanapolipoproteina2inapolipoproteinedeficientmiceinducesfeaturesoffamilialcombinedhyperlipidemia‏ ‎‡A Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia‏ ‎‡9 1‏
919 ‎‡a enhancedvascularpermeabilityfacilitatesentryofplasmahdlandpromotesmacrophagereversecholesteroltransportfromskininmice‏ ‎‡A Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.‏ ‎‡9 1‏
919 ‎‡a effectsofvirginoliveoilandphenolenrichedvirginoliveoilsonlipoproteinatherogenicity‏ ‎‡A Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity‏ ‎‡9 1‏
919 ‎‡a differentialeffectsofgemfibrozilandfenofibrateonreversecholesteroltransportfrommacrophagestofecesinvivo‏ ‎‡A Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.‏ ‎‡9 1‏
919 ‎‡a dietaryphytosterolsmodulatethelperimmuneresponsebutdonotinduceapparentantiinflammatoryeffectsinamousemodelofacuteasepticinflammation‏ ‎‡A Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation‏ ‎‡9 1‏
919 ‎‡a crosstalkbetweeninflammatorymediatorsandtheepithelialmesenchymaltransitionprocessinthedevelopmentofthyroidcarcinoma‏ ‎‡A Cross-Talk between Inflammatory Mediators and the Epithelial Mesenchymal Transition Process in the Development of Thyroid Carcinoma.‏ ‎‡9 1‏
919 ‎‡a clinicallyusedselectiveestrogenreceptormodulatorsaffectdifferentstepsofmacrophagespecificreversecholesteroltransport‏ ‎‡A Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport‏ ‎‡9 1‏
919 ‎‡a chylomicronsadvancesinbiologypathologylaboratorytestingandtherapeutics‏ ‎‡A Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.‏ ‎‡9 1‏
919 ‎‡a chronicintermittentpsychologicalstresspromotesmacrophagereversecholesteroltransportbyimpairingbileacidabsorptioninmice‏ ‎‡A Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice‏ ‎‡9 1‏
919 ‎‡a cholesteroleffluxandreversecholesteroltransport‏ ‎‡A Cholesterol efflux and reverse cholesterol transport‏ ‎‡9 1‏
919 ‎‡a cholesteroland27hydroxycholesterolpromotethyroidcarcinomaaggressiveness‏ ‎‡A Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness‏ ‎‡9 1‏
919 ‎‡a cetpactivityvariationinmicedoesnotaffect2majorhdlantiatherogenicpropertiesmacrophagespecificreversecholesteroltransportandldlantioxidantprotection‏ ‎‡A CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection‏ ‎‡9 1‏
919 ‎‡a atpbindingcassetteg5g8deficiencycauseshypertriglyceridemiabyaffectingmultiplemetabolicpathways‏ ‎‡A ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways.‏ ‎‡9 1‏
919 ‎‡a arelxrregulatedgenesamajormoleculartargetofplantsterolsstanols‏ ‎‡A Are LXR-regulated genes a major molecular target of plant sterols/stanols?‏ ‎‡9 1‏
919 ‎‡a apolipoproteinmimeticsincancer‏ ‎‡A Apolipoprotein Mimetics in Cancer‏ ‎‡9 1‏
919 ‎‡a apoa1oxidationisassociatedtodysfunctionalhighdensitylipoproteinsinhumanabdominalaorticaneurysm‏ ‎‡A APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm.‏ ‎‡9 1‏
919 ‎‡a apoa1mimeticadministrationbutnotincreasedapoa1containinghdlinhibitstumourgrowthinamousemodelofinheritedbreastcancer‏ ‎‡A ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.‏ ‎‡9 1‏
919 ‎‡a antiatherogenicroleofhighdensitylipoproteinsinsightsfromgeneticallyengineeredmice‏ ‎‡A Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice‏ ‎‡9 1‏
919 ‎‡a alteredbrainmetabolomeisassociatedwithmemoryimpairmentinthertg4510mousemodeloftauopathy‏ ‎‡A Altered Brain Metabolome Is Associated with Memory Impairment in the rTg4510 Mouse Model of Tauopathy‏ ‎‡9 1‏
919 ‎‡a administrationofcorm2inhibitsdiabeticneuropathybutdoesnotreducedyslipidemiaindiabeticmice‏ ‎‡A Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice‏ ‎‡9 1‏
919 ‎‡a functionalvirginoliveoilenrichedwitholiveoilandthymephenoliccompoundsimprovestheexpressionofcholesteroleffluxrelatedgenesarandomizedcrossovercontrolledtrial‏ ‎‡A A Functional Virgin Olive Oil Enriched with Olive Oil and Thyme Phenolic Compounds Improves the Expression of Cholesterol Efflux-Related Genes: A Randomized, Crossover, Controlled Trial‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 BNC|981058517783206706‏
996 ‎‡2 ISNI|0000000383968270‏
996 ‎‡2 BNE|XX847853‏
996 ‎‡2 DNB|129300772‏
996 ‎‡2 ISNI|0000000071414332‏
996 ‎‡2 NUKAT|n 2007078225‏
996 ‎‡2 BNE|XX1079009‏
996 ‎‡2 DNB|17316479X‏
996 ‎‡2 ISNI|0000000059984279‏
996 ‎‡2 LC|n 89124000‏
996 ‎‡2 BNC|981058508798506706‏
996 ‎‡2 BNC|981058518694806706‏
996 ‎‡2 JPG|500038972‏
996 ‎‡2 BNE|XX5009544‏
996 ‎‡2 LC|n 2013032362‏
996 ‎‡2 SUDOC|228522714‏
996 ‎‡2 BNC|981058612232906706‏
996 ‎‡2 SUDOC|227292278‏
996 ‎‡2 NYNYRILM|64724‏
996 ‎‡2 ISNI|0000000060213893‏
996 ‎‡2 BNE|XX5094083‏
996 ‎‡2 BNC|981058516044606706‏
996 ‎‡2 BNC|981058612785906706‏
996 ‎‡2 BNC|981058517205906706‏
996 ‎‡2 BNE|XX1012910‏
996 ‎‡2 LC|n 98038746‏
996 ‎‡2 ISNI|000000051119715X‏
996 ‎‡2 PLWABN|9810688510505606‏
996 ‎‡2 BNC|981058528473606706‏
996 ‎‡2 BNE|XX990997‏
996 ‎‡2 SUDOC|28151366X‏
996 ‎‡2 DNB|1057278777‏
996 ‎‡2 LC|no2006096608‏
996 ‎‡2 LC|no2017129781‏
996 ‎‡2 BNF|18078339‏
996 ‎‡2 LC|no2012152795‏
996 ‎‡2 BNC|981058519284206706‏
996 ‎‡2 NUKAT|n 96030936‏
996 ‎‡2 ISNI|0000000116051302‏
996 ‎‡2 ISNI|0000000037866781‏
996 ‎‡2 SUDOC|139615830‏
996 ‎‡2 BNC|981058610969006706‏
996 ‎‡2 BNC|981058522877506706‏
996 ‎‡2 PTBNP|192977‏
996 ‎‡2 BNE|XX961393‏
996 ‎‡2 ISNI|0000000066380385‏
996 ‎‡2 BNE|XX880284‏
996 ‎‡2 LC|n 88032666‏
996 ‎‡2 BNE|XX1107446‏
996 ‎‡2 ISNI|0000000021931120‏
996 ‎‡2 NUKAT|n 2014093402‏
996 ‎‡2 NUKAT|nx2023942389‏
996 ‎‡2 ISNI|0000000067782634‏
996 ‎‡2 NII|DA04565226‏
996 ‎‡2 ISNI|0000000059226291‏
996 ‎‡2 J9U|987007279010705171‏
996 ‎‡2 BNC|981058510691106706‏
996 ‎‡2 BNE|XX1725204‏
996 ‎‡2 BNE|XX870674‏
996 ‎‡2 BNE|XX1323371‏
996 ‎‡2 BNC|981058510125506706‏
996 ‎‡2 NSK|000477887‏
996 ‎‡2 BNE|XX1539611‏
996 ‎‡2 ISNI|0000000070852306‏
996 ‎‡2 BNE|XX878491‏
996 ‎‡2 NTA|070405921‏
996 ‎‡2 ISNI|0000000118755522‏
996 ‎‡2 DNB|171823605‏
996 ‎‡2 NTA|159676835‏
996 ‎‡2 ISNI|0000000121452629‏
996 ‎‡2 ISNI|0000000409524804‏
996 ‎‡2 BIBSYS|90536978‏
996 ‎‡2 RERO|A012469065‏
996 ‎‡2 LC|no2002004044‏
996 ‎‡2 BNC|981060960146006706‏
996 ‎‡2 LC|n 81097377‏
996 ‎‡2 DNB|136468233‏
996 ‎‡2 BNC|981058509851006706‏
996 ‎‡2 SUDOC|235063614‏
996 ‎‡2 LC|n 2009060971‏
996 ‎‡2 LC|n 2004010817‏
996 ‎‡2 ISNI|000000007827255X‏
996 ‎‡2 DNB|1184426686‏
996 ‎‡2 JPG|500035355‏
996 ‎‡2 SUDOC|19313036X‏
996 ‎‡2 ISNI|0000000072257615‏
996 ‎‡2 RERO|A003295838‏
996 ‎‡2 BNE|XX882665‏
996 ‎‡2 BNE|XX862141‏
996 ‎‡2 PLWABN|9811554355305606‏
996 ‎‡2 LC|n 88104740‏
996 ‎‡2 JPG|500141734‏
996 ‎‡2 PLWABN|9810568857105606‏
996 ‎‡2 ISNI|0000000373446380‏
996 ‎‡2 LC|n 78091886‏
996 ‎‡2 BNC|981058525972406706‏
996 ‎‡2 SUDOC|124068294‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏